CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Jan 21, 2016
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Purchase
Common Stock
2016-01-19$0.74/sh+1,100$814→ 8,637 total - Purchase
Common Stock
2016-01-19$0.72/sh+6,063$4,365→ 14,700 total - Purchase
Common Stock
2016-01-19$0.73/sh+7,537$5,502→ 7,537 total - Purchase
Common Stock
2016-01-19$0.71/sh+300$213→ 15,000 total